Affiliation:
1. Department of Biochemistry and Molecular Biology‐A University of Murcia Murcia 30071 Spain
2. Department of Cardiology Hospital Clínico Universitario Virgen de la Arrixaca Murcia 30120 Spain
3. Proteomic Unit Instituto Murciano de Investigaciones Biosanitarias Pascual Parrilla (IMIB‐Pascual Parrilla) Murcia Spain
Abstract
ScopeHigh blood pressure (BP) is the main preventable risk factor for cardiovascular diseases (CVDs). Much research is aimed at finding natural alternatives to control or prevent hypertension (HT), since some hypertensive patients do not respond to current pharmacological treatments or show undesirable side effects.Methods and resultsForty relevant articles have been selected from various scientific literature databases. The results reveal that angiotensin‐converting enzyme (ACE) inhibition is the most reported mechanism of action of antihypertensive peptides. The active peptides have a great variety of origins. Biopeptides with a molecular weight of <3 kDa, short chain <20 amino acids, and a hydrophobic amino acid sequence at the C‐ and N‐terminus exhibit higher antihypertensive activity. They also show good stability to enzymatic hydrolysis and gastrointestinal digestion, and no toxicity. To determine antihypertensive effectiveness, in vitro and in vivo animal studies are the most frequent developed, with few in silico studies and only one human clinical trial.ConclusionThere is interesting potential for antihypertensive peptides as promising natural candidates for the development of functional foods, nutraceuticals and drugs for preventive or therapeutic treatment of hypertension. The aim of this review is to study the role of food‐derived bioactive peptides in HT.